Pharmafile Logo
Pharmafocus logo
Advanced Search
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …

Appointment
Lucentis image

Lucentis not backed by NICE for new licence

November 24, 2011
Sales and Marketing Lucentis, NICE, Novartis, Ozurdex

NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …

News
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Appointment

Private sector role in NHS commissioning opposed

November 23, 2011
Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters

Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …

News

Future of public health uncertain, says Forum

November 23, 2011
Sales and Marketing Future Forum, NHS, NHS reforms

The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …

News
Alasdair Williams

Red Door launches Grapevine ‘localisation’ service

November 23, 2011
Medical Communications Grapevine, Red Door

 Red Door Communications has launched Grapevine – a new healthcare ‘localisation’ initiative and appointed Alasdair Williams as its head. Grapevine …

News

Pfizer hatches mail order plan for Lipitor

November 23, 2011
Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …

News

Big pharma counts cost of R&D decline

November 23, 2011
Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

News
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011
Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

News

Pharmalink elects Anders Wiklund as its new board chairman

November 23, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …

Appointment

Pancreatic cancer sees lowest improvement in cancer survival

November 23, 2011
Medical Communications, Research and Development Cancer, Macmillan, pancreatic

A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates.  The study …

News

Changes to the EMA’s registration process for SMEs

November 22, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …

News
Press release

Doxil shortages exacerbated as Ben Venue shutters plant

November 22, 2011
Manufacturing and Production Doxil, J&J, JJ, manufacturing and production

An acute shortage of Johnson & Johnson’s cancer drug Doxil (doxorubicin) in the US could get worse following a decision …

News

Pharma manufacturing news in brief

November 22, 2011
Manufacturing and Production manufacturing and production

Pfizer and Julphar plan facilities in Saudi Arabia, plus updates from Custom Processing Services, Metrics and China’s Tianyin Pharma. Gulf …

News

Contract research news in brief

November 22, 2011
Manufacturing and Production manufacturing and production

UCB forges strategic alliances with Parexel and PRA, Icon wins a contract for a phase III trial of a traditional …

News

AstraZeneca appoints two new senior leaders in its Americas division

November 22, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca

AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …

Appointment

Thomas Thorp promoted to senior director of corporate affairs at Lilly UK

November 22, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly

Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …

Appointment
Eylea picture

Lucentis rival gains US approval

November 22, 2011
Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

News

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011
Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …

News
Willetts opens the new Celgene headquarters

Celgene opens new headquarters in UK

November 21, 2011
Research and Development, Sales and Marketing Celgene

Celgene has opened new UK headquarters in London as its haematology-based business expands. The firm says it has decided to …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026